ALLHAT was groundbreaking at the time of its design in its comparison of classically used diuretics with the more novel CCB and ACE inhibitor drugs in terms of “fatal coronary heart disease (CHD) incidence” as well as other CVD events.7 Here, ACE is linked to coronary artery disorder.